Skip to main content

Table 1 Clinical characteristics according to metabolic health group

From: Dietary patterns and physical activity in the metabolically (un)healthy obese: the Dutch Lifelines cohort study

  Men Women
  MUO Intermediate MHO MUO Intermediate MHO
N 1959 (56.9) 1131 (32.9) b 352 (10.2) b 2058 (35.3) 2348 (40.3) b 1422 (24.4) b
Age (years) 49.4 ± 9.4 49.6 ± 9.5 45.3 ± 8.6 b 50.6 ± 9.4 48.3 ± 9.9 b 44.9 ± 8.3 b
BMI (kg/m2) 32.2 [30.9–34.3] 31.8 [30.7–33.4] b 31.4 [30.7–32.9] b 33.6 [31.5–36.7] 32.8 [31.2–35.4] b 32.1 [30.9–34.4] b
Waist circumference (cm) 113.0 ± 9.0 111.1 ± 8.2 b 108.9 ± 7.2 b 108.0 ± 10.7 104.0 ± 9.6 b 101.4 ± 8.9 b
Systolic BP (mmHg) 139 ± 14 137 ± 14 b 122 ± 6 b 135 ± 15 131 ± 16 b 118 ± 7 b
Diastolic BP (mmHg) 81 ± 9 81 ± 9 74 ± 5 b 77 ± 9 75 ± 9 b 70 ± 6 b
Fasting glucose (mmol/L) 5.5 [5.1–6.2] 5.2 [5.0–5.6] b 5.2 [4.9–5.5] b 5.5 [5.0–6.3] 5.0 [4.7–5.4] b 4.9 [4.7–5.2] b
HDL cholesterol (mmol/L) 1.02 ± 0.21 1.28 ± 0.25 b 1.33 ± 0.20 b 1.20 ± 0.27 1.48 ± 0.33 b 1.58 ± 0.26 b
Triglycerides (mmol/L) 2.04 [1.60–2.72] 1.21 [0.96–1.50] b 1.08 [0.85–1.34] b 1.76 [1.25–2.21] 1.06 [0.82–1.35] b 0.91 [0.72–1.15] b
Type 2 diabetes * (%) 10.5 0.6 b 0.0 13.3 0.8 b 0.0
CVD history (%) 4.7 4.2 0.0 2.7 1.4 0.0
Use of BP lowering drugs 33.0 20.4 b 0.0 44.4 24.7 b 0.0
  1. Data are presented as mean ± SD or median [interquartile range] or percentage (%). a denotes a P ≤ 0.01 and b denotes a P ≤ 0.0001 compared to MUO
  2. MHO metabolically healthy obesity, MUO metabolically unhealthy obesity, BMI body mass index, BP blood pressure, HDL high-density lipoprotein, CVD cardiovascular disease. * Based on known type 2 diabetes and newly-diagnosed type 2 diabetes (defined as a single fasting plasma glucose level ≥ 7.0 mmol/L)